Cor Vasa 2014, 56(6):687-688

Riociguat - první prokazatelně účinná farmakoterapie u pacientů s inoperabilní a reziduální chronickou tromboembolickou plicní hypertenzí

Doc. MUDr. Pavel Jansa, Ph.D.
Centrum pro plicní hypertenzi, II. interní klinika kardiologie a angiologie, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice, Praha

Published: December 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jansa P. Riociguat - první prokazatelně účinná farmakoterapie u pacientů s inoperabilní a reziduální chronickou tromboembolickou plicní hypertenzí. Cor Vasa. 2014;56(6):687-688.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. N.H. Kim, M. Delcroix, D.P. Jenkins, et al., Chronic thromboembolic pulmonary hypertension, Journal of the American College of Cardiology 62 (25 Suppl) (2013) D92-D99. Go to original source... Go to PubMed...
    2. J. Pepke-Zaba, M. Delcroix, I. Lang, et al., Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry, Circulation 124 (2011) 1973-1981. Go to original source... Go to PubMed...
    3. J. Pepke-Zaba, P. Jansa, N.H. Kim, et al., Chronic thromboembolic pulmonary hypertension: role of medical therapy, European Respiratory Journal 41 (2013) 985-990. Go to original source... Go to PubMed...
    4. H. Olschewski, G. Simonneau, N. Galiè, et al., Inhaled iloprost for severe pulmonary hypertension, New England Journal of Medicine 347 (2002) 322-329. Go to original source... Go to PubMed...
    5. J. Suntharalingam, C.M. Treacy, N.J. Doughty, et al., Long-term use of sildenafil in inoperable chronic thromboembolic pulmonary hypertension, Chest 134 (2008) 229-236. Go to original source... Go to PubMed...
    6. X. Jaïs, A.M. D'Armini, P. Jansa, et al., Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial, Journal of the American College of Cardiology 52 (2008) 2127-2134. Go to original source... Go to PubMed...
    7. H.A. Ghofrani, A.M. D'Armini, F. Grimminger, at el., Riociguat for the treatment of chronic thromboembolic pulmonary hypertension, New England Journal of Medicine 369 (2013) 319-329. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes